Eva Nordström
Chief Operating Officer at ONCOPEPTIDES AB
Net worth: 51 319 $ as of 2024-05-30
Network origin in Eva Nordström first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 33 | |
Oxcia AB
3
| Private Company | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Eva Nordström via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Uppsala | College/University | Graduate Degree Doctorate Degree Doctorate Degree Masters Business Admin Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree | |
Oncopeptides Incentive AB | Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member | ||
Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Investor Relations Contact Director of Finance/CFO Investor Relations Contact General Counsel General Counsel | |
University of Stockholm | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Graduate Degree | |
ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member Investor Relations Contact Director/Board Member | |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer Director/Board Member | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
Pfizer AB | Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact | ||
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Private Equity Investor Private Equity Investor | |
Ancilla AB
Ancilla AB Real Estate DevelopmentFinance Ancilla AB manages real properties. The company is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member Director/Board Member | |
CAMURUS AB | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
Targovax Oy
Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Chairman Director/Board Member | |
MEDIVIR AB | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
Odlander, Fredrikson & Co. AB
Odlander, Fredrikson & Co. AB Financial ConglomeratesFinance Odlander Fredrikson & Co. AB provides financial support services. The company was founded in 1996 and is headquartered in Stockholm, Sweden. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
Glionova AB
Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
CIRCIO HOLDING ASA | Biotechnology | Director/Board Member Director/Board Member | |
ASTRAZENECA PLC | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
RECIPHARM AB (PUBL) | Biotechnology | Director/Board Member Public Communications Contact | |
Healthcap 1999 GP AB
Healthcap 1999 GP AB Investment Banks/BrokersFinance Part of Odlander, Fredrikson & Co. AB, Healthcap 1999 GP AB is a company that manages and trades securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
Healthcap Orx Holdings Gp AB
Healthcap Orx Holdings Gp AB Investment Banks/BrokersFinance Healthcap Orx Holdings Gp AB is a private company that manages securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
Healthcap Aero Holdings Gp | Director/Board Member Director/Board Member | ||
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
Celgene AB | Corporate Officer/Principal Corporate Officer/Principal | ||
Oncopeptides, Inc.
Oncopeptides, Inc. Medical/Nursing ServicesHealth Services Part of Oncopeptides AB, Oncopeptides, Inc. is a company committed to developing therapies for difficult-to-treat hematological diseases. The company is based in Waltham, MA. Oncopeptides strives to bring hope to patients through science and innovation, and is dedicated to bringing forward new and meaningful treatment options. The company is inspired by the perseverance of patients, caregivers, and healthcare providers in their fight against cancer. Oncopeptides' focus is on the development of therapies that can make a difference in the lives of those affected by hematological diseases. | Medical/Nursing Services | Chairman Director/Board Member | |
University of Gothenburg | College/University | Doctorate Degree Undergraduate Degree | |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
RAYSEARCH LABORATORIES AB | Packaged Software | Director of Finance/CFO Director of Finance/CFO | |
CANTARGIA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
RYVU THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
Bluefish Pharmaceuticals AB
Bluefish Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Bluefish Pharmaceuticals AB manufactures generic pharmaceutical products. Its therapeutic areas include analgesic, antibiotics, antifungal, antiviral, cardiovascular, endocrinology, diabetes, gastrointestinal, genito-urinary, inflammatory, oncology, and respiratory. The company was founded by Karl Alexius Tiger Karlsson in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Swedish Pharmaceutical Society | Chairman | ||
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Medical Distributors | Director/Board Member | |
CarpoNovum AB
CarpoNovum AB Medical SpecialtiesHealth Technology CarpoNovum AB develops and provides surgical instruments. Its products include CARP RapAn, CARP FixAid, CARP FixAid no cath, CARP LapAid, CARP DMHC, CARP pressure measure device and CARP test devices. The company was founded by Henrik Tobias Thorlacius and Grönberg Anders Georg in 2006 and is headquartered in Halmstad, Sweden. | Medical Specialties | Director/Board Member | |
TME PHARMA N.V. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Apotekarsocieteten | Chairman | ||
DICOT PHARMA AB | Pharmaceuticals: Major | Chairman |
Statistics
International
Sweden | 38 |
United States | 6 |
Norway | 4 |
Finland | 2 |
United Kingdom | 2 |
Sectoral
Health Technology | 27 |
Finance | 7 |
Consumer Services | 5 |
Commercial Services | 4 |
Health Services | 3 |
Operational
Director/Board Member | 190 |
Corporate Officer/Principal | 77 |
Chairman | 40 |
Independent Dir/Board Member | 40 |
Chief Executive Officer | 34 |
Most connected contacts
- Stock Market
- Insiders
- Eva Nordström
- Company connections